{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:18:52Z","timestamp":1791875932659,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016386","name":"Government of Valencia Ministry of Innovation Universities Science and Society","doi-asserted-by":"publisher","award":["CIAICO\/2022\/081"],"award-info":[{"award-number":["CIAICO\/2022\/081"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["UGP-20\\u2013135"],"award-info":[{"award-number":["UGP-20\\u2013135"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI08\/0901"],"award-info":[{"award-number":["PI08\/0901"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI22\/00824"],"award-info":[{"award-number":["PI22\/00824"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI12\/02025"],"award-info":[{"award-number":["PI12\/02025"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019157","name":"Foundation for the Promotion of the Research in Healthcare and Biomedicine of the Valencian Community","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118541","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:42:53Z","timestamp":1757677373000},"page":"118541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Insights into histone deacetylase inhibitors-induced cell death in cancer cell lines"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3653-2407","authenticated-orcid":false,"given":"Mar\u00eda","family":"Fuentes-Baile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8424-4613","authenticated-orcid":false,"given":"Pilar","family":"Garc\u00eda-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-0592","authenticated-orcid":false,"given":"Elizabeth","family":"P\u00e9rez-Valenciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Mata-Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8045-2995","authenticated-orcid":false,"given":"Mar\u00eda P.","family":"Men\u00e9ndez-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-8447","authenticated-orcid":false,"given":"Camino","family":"de Juan Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Rodr\u00edguez-Lescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6303-481X","authenticated-orcid":false,"given":"Elena","family":"Mart\u00edn-Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8058-1009","authenticated-orcid":false,"given":"Ricardo","family":"Mallavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor M.","family":"Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-3602","authenticated-orcid":false,"given":"Miguel","family":"Saceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncponc0106","article-title":"Drug insight: histone deacetylase inhibitors - development of the new targeted anticancer agent suberoylanilide hydroxamic acid","volume":"2","author":"Kelly","year":"2005","journal-title":"Nat. Clin. Pr. Oncol."},{"issue":"20","key":"10.1016\/j.biopha.2025.118541_bib2","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/jcmm.13475","article-title":"Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor trichostatin a","volume":"22","author":"Xu","year":"2018","journal-title":"J. Cell Mol. Med"},{"issue":"11","key":"10.1016\/j.biopha.2025.118541_bib4","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/cancers11111794","article-title":"HDAC inhibitors in acute myeloid leukemia","volume":"11","author":"Jos\u00e9-En\u00e9riz","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ijc.10998","article-title":"Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors","volume":"104","author":"Castro-Galache","year":"2003","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2025.118541_bib6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1535-7163.MCT-04-0186","article-title":"Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines","volume":"4","author":"Garc\u00eda-Morales","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.biopha.2025.118541_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/cancers13040634","article-title":"Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives","volume":"13","author":"Jenke","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118541_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175216","article-title":"The emerging roles of HDACs and their therapeutic implications in cancer","volume":"931","author":"Hai","year":"2022","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2008.01.009","article-title":"A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study","volume":"109","author":"Modesitt","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10637-008-9131-6","article-title":"Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer","volume":"26","author":"Vansteenkiste","year":"2008","journal-title":"Invest N. Drugs"},{"issue":"9","key":"10.1016\/j.biopha.2025.118541_bib11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ejca.2010.02.047","article-title":"Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours","volume":"46","author":"Mackay","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/annonc\/mdp270","article-title":"Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)","volume":"21","author":"Molife","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118541_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and challenges of HDAC inhibitors in cancer therapeutics","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res"},{"issue":"17","key":"10.1016\/j.biopha.2025.118541_bib14","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1016\/j.bmcl.2017.07.054","article-title":"Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4\/HDAC inhibitors","volume":"27","author":"Shao","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3390\/molecules27030715","article-title":"HDAC inhibitors: innovative strategies for their design and applications","volume":"27","author":"Dasko","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.9","article-title":"HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses","volume":"4","author":"Bolden","year":"2013","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118541_bib17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118541_bib18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/ijms20071601","article-title":"Apoptosis induction by histone deacetylase inhibitors in cancer cells: role of Ku70","volume":"20","author":"Gong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib19","first-page":"310","article-title":"Effect of zebularine in comparison to trichostatin a on the intrinsic and extrinsic apoptotic pathway, cell viability, and apoptosis in hepatocellular carcinoma SK-Hep 1, human colorectal cancer SW620, and human pancreatic cancer PaCa-44 cell lines","volume":"20","author":"Sanaei","year":"2021","journal-title":"Iran. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cells8010008","article-title":"Differential mechanisms of cell death induced by HDAC inhibitor SAHA and MDM2 inhibitor RG7388 in MCF-7 cells","volume":"8","author":"Natarajan","year":"2018","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2025.118541_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.2434","article-title":"SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway","volume":"216","author":"Hrzenjak","year":"2008","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jcb.20278","article-title":"Differentiation and drug resistance relationships in leukemia cells","volume":"94","author":"Camarasa","year":"2005","journal-title":"J. Cell Biochem."},{"issue":"15","key":"10.1016\/j.biopha.2025.118541_bib23","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/0959-8049(93)90050-P","article-title":"Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells","volume":"29A","author":"Soto","year":"1993","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212581","article-title":"Radiotherapy resistance acquisition in glioblastoma. Role of SOCS1 and SOCS3","volume":"14","author":"Ventero","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/joe.0.1800497","article-title":"Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells","volume":"180","author":"Angeloni","year":"2004","journal-title":"J. Endocrinol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118541_bib26","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.3390\/ijms21228522","article-title":"Cell death mechanisms induced by CLytA-DAAO chimeric enzyme in human tumor cell lines","volume":"21","author":"Fuentes-Baile","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"D1","key":"10.1016\/j.biopha.2025.118541_bib27","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"50","key":"10.1016\/j.biopha.2025.118541_bib28","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1038\/sj.onc.1203176","article-title":"Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2\/Bcl-XL, c-Jun, and p21CIP1, but independent of p53","volume":"18","author":"Vrana","year":"1999","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12935-016-0343-0","article-title":"Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway","volume":"16","author":"Fr\u00f6hlich","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.biopha.2025.118541_bib30","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/ijms20102415","article-title":"p53 at the crossroads between different types of HDAC Inhibitor-Mediated cancer cell death","volume":"20","author":"Mrakovcic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009118","article-title":"Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2\/U19","volume":"5","author":"Wan","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064576","article-title":"Eafs control erythroid cell fate by regulating c-myb expression through wnt signaling","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib33","first-page":"2795","article-title":"Eaf2 protects human lens epithelial cells against oxidative stress-induced apoptosis by wnt signaling","volume":"17","author":"Feng","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ydbio.2019.04.010","article-title":"Distinct transcriptional regulation of Nanos2 in the germ line and soma by the wnt and delta\/notch pathways","volume":"452","author":"Oulhen","year":"2019","journal-title":"Dev. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006055","article-title":"Essential roles of cyclin Y-Like 1 and cyclin y in dividing Wnt-Responsive mammary Stem\/Progenitor cells","volume":"12","author":"Zeng","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2025.118541_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112904","article-title":"Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors","volume":"209","author":"Bass","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118541_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcancer.2021.03.001","article-title":"Targeting the acetylation signaling pathway in cancer therapy","volume":"85","author":"Dang","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3892\/ijo.2010.879","article-title":"HDAC inhibitors downregulate MRP2 expression in multidrug resistant cancer cells: implication for chemosensitization","volume":"38","author":"Kim","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/jcmm.13475","article-title":"Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor trichostatin a","volume":"22","author":"Xu","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2025.118541_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2407-13-286","article-title":"The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells","volume":"13","author":"Kerl","year":"2013","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118541_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/10408440590935639","article-title":"Differential effects of histone deacetylase inhibitors in tumor and normal Cells\u2014What is the toxicological relevance?","volume":"35","author":"Papeleu","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jhep.2004.05.018","article-title":"Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells","volume":"41","author":"Chiba","year":"2004","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbrc.2018.11.143","article-title":"Gene microarray analysis of expression profiles in suberoyllanilide hyroxamic acid-treated dendritic cells","volume":"508","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib44","first-page":"384","article-title":"The histone deacetylase inhibitor trichostatin a induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways","volume":"28","author":"Meng","year":"2012","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11060-011-0791-2","article-title":"P53-dependent antiproliferative and pro-apoptotic effects of trichostatin a (TSA) in glioblastoma cells","volume":"107","author":"Bajbouj","year":"2012","journal-title":"J. Neurooncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/cc.11.2.18758","article-title":"Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.biopha.2025.118541_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1593\/neo.04655","article-title":"Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma","volume":"7","author":"Fandy","year":"2005","journal-title":"Neoplasia"},{"issue":"9","key":"10.1016\/j.biopha.2025.118541_bib48","doi-asserted-by":"crossref","first-page":"13061","DOI":"10.3390\/molecules190913061","article-title":"Effects of P-Glycoprotein and its inhibitors on apoptosis in K562 cells","volume":"19","author":"Zu","year":"2014","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.biopha.2025.118541_bib49","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.exphem.2011.07.002","article-title":"The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors","volume":"39","author":"J\u00f3na","year":"2011","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/mol.109.056309","article-title":"BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing","volume":"76","author":"Pandya Martin","year":"2009","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2025.118541_bib51","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/cells9071661","article-title":"Inhibition of HDAC1\/2 along with TRAP1 causes synthetic lethality in glioblastoma model systems","volume":"9","author":"Nguyen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118541_bib52","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.2147\/DDDT.S89392","article-title":"Chamaejasmin b exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des. Devel Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113681","article-title":"Targeting nanog expression increased cisplatin chemosensitivity and inhibited cell migration in gastric cancer cells","volume":"429","author":"Vasefifar","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118541_bib54","first-page":"323","article-title":"Effects of trichostatin a on the intrinsic and extrinsic apoptotic pathway, cell viability, and apoptosis induction in hepatocellular carcinoma cell lines","volume":"14","author":"Sanaei","year":"2021","journal-title":"Gastroenterol. Hepatol. Bed. Bench"},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamcr.2004.07.001","article-title":"Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin a reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells","volume":"1693","author":"Moore","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.biopha.2025.118541_bib56","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1535-7163.MCT-10-0141","article-title":"PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells","volume":"9","author":"Kim","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"14","key":"10.1016\/j.biopha.2025.118541_bib57","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1074\/jbc.M213093200","article-title":"Role of caspases, bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors Trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA)","volume":"278","author":"Henderson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118541_bib58","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/ijo.2014.2550","article-title":"Histone deacetylase inhibitors induce attenuation of wnt signaling and TCF7L2 depletion in colorectal carcinoma cells","volume":"45","author":"G\u00f6tze","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-007-9837-8","article-title":"Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells","volume":"112","author":"Domingo-Dom\u00e8nech","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.biopha.2025.118541_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/07357907.2010.496756","article-title":"Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341","volume":"29","author":"Fang","year":"2011","journal-title":"Cancer Invest."},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib61","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11064-011-0411-8","article-title":"Endoplasmic reticulum calcium release engages bax translocation in cortical astrocytes","volume":"36","author":"Morales","year":"2011","journal-title":"Neurochem. Res."},{"issue":"10","key":"10.1016\/j.biopha.2025.118541_bib62","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.08-124354","article-title":"BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion","volume":"23","author":"Zhang","year":"2009","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.immuni.2007.05.023","article-title":"The proapoptotic factors bax and bak regulate t cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis","volume":"27","author":"Jones","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biopha.2025.118541_bib64","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bcp.2005.04.030","article-title":"HDAC inhibition prevents NF-\u03baB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes I\u03baB\u03b1","volume":"70","author":"Place","year":"2005","journal-title":"Biochem. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118541_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13815","article-title":"DNA damage repair in glioblastoma: a novel approach to combat drug resistance","volume":"58","author":"Gaiaschi","year":"2025","journal-title":"Cell Prolif."},{"issue":"53","key":"10.1016\/j.biopha.2025.118541_bib66","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1038\/sj.onc.1207108","article-title":"Regulation of apoptosis by endoplasmic reticulum pathways","volume":"22","author":"Breckenridge","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118541_bib67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2018.01.006","article-title":"Histone deacetylase inhibition-mediated neuronal differentiation via the wnt signaling pathway in human adipose tissue-derived mesenchymal stem cells","volume":"668","author":"Jang","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2025.118541_bib68","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.30664","article-title":"A histone deacetylase inhibitor enhances expression of genes inhibiting wnt pathway and augments activity of DNA demethylation reagent against nonsmall-cell lung cancer","volume":"140","author":"Shieh","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4062\/biomolther.2022.022","article-title":"CKD-581 downregulates Wnt\/\u03b2-Catenin pathway by DACT3 induction in hematologic malignancy","volume":"30","author":"Kim","year":"2022","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib70","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/cancers13020259","article-title":"Epigenetic modulation of SPCA2 reverses epithelial to mesenchymal transition in breast cancer cells","volume":"13","author":"Makena","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118541_bib71","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.2147\/IJN.S234636","article-title":"Targeting tumorigenicity of breast cancer stem cells using SAHA\/Wnt-b catenin antagonist loaded onto protein corona of gold nanoparticles","volume":"15","author":"Shamsian","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.biopha.2025.118541_bib72","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41388-019-1045-6","article-title":"MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt\/\u03b2-catenin signaling pathway","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118541_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2017.04.028","article-title":"In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor","volume":"400","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.biopha.2025.118541_bib74","article-title":"Lactylation of HDAC1 confers resistance to ferroptosis in colorectal cancer","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib75","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0263-18.2019","article-title":"Ferroptosis in neurons and cancer cells is similar but differentially regulated by histone deacetylase inhibitors","volume":"6","author":"Zille","year":"2019","journal-title":"eNeuro"},{"issue":"8","key":"10.1016\/j.biopha.2025.118541_bib76","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s11064-017-2249-1","article-title":"The contribution of necroptosis in neurodegenerative diseases","volume":"42","author":"Shao","year":"2017","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib77","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3892\/mmr.2015.3779","article-title":"Inhibiting histone deacetylase 6 partly protects cultured rat cortical neurons from oxygen-glucose deprivation-induced necroptosis","volume":"12","author":"Yuan","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118541_bib78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jnc.13029","article-title":"Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway","volume":"133","author":"Bollino","year":"2015","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113629","article-title":"Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors","volume":"43","author":"Karagiannis","year":"2024","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118541_bib80","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/biom10101466","article-title":"Gene expression profiling of multiple histone deacetylases (HDAC) and its correlation with NRF2-mediated redox regulation in the pathogenesis of diabetic foot ulcers","volume":"10","author":"Teena","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118541_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111583","article-title":"HDAC inhibitor enhances ferroptosis susceptibility of AML cells by stimulating iron metabolism","volume":"127","author":"Bian","year":"2025","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.biopha.2025.118541_bib82","article-title":"Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzheimer\u2019s disease by activating the Wnt\/\u03b2-catenin signaling","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118541_bib83","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.7150\/ijbs.106357","article-title":"PROTAC-Surufatinib suppresses pancreatic neuroendocrine neoplasms progression by inducing ferroptosis through inhibiting WNT\/\u03b2-catenin pathway mediated by HMOX1","volume":"21","author":"Xue","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118541_bib84","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1007\/s12035-025-04841-5","article-title":"MGST1 inhibits Sevoflurane-Induced ferroptosis and activates the wnt pathway in HT22 cells","volume":"62","author":"Gao","year":"2025","journal-title":"Mol. Neurobiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:49:13Z","timestamp":1772848153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":84,"alternative-id":["S0753332225007358"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118541","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into histone deacetylase inhibitors-induced cell death in cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118541"}}